浏览全部资源
扫码关注微信
1.湖北民族大学 附属荆门市第一人民医院,湖北 荆门 448000
2.风湿性疾病发生与干预湖北省重点实验室,湖北 恩施 445000
3.华中科技大学 同济医学院 基础医学院,武汉 430011
Published:20 December 2021,
Published Online:27 October 2021,
Received:13 July 2021,
扫 描 看 全 文
卢志刚,杨昌明,孔祥辉等.醒脑开窍中药治疗脑缺血再灌注损伤作用机制的研究进展[J].中国实验方剂学杂志,2021,27(24):235-242.
LU Zhi-gang,YANG Chang-ming,KONG Xiang-hui,et al.Mechanism of Chinese Medicine in Xingnao and Kaiqiao Against Cerebral Ischemia/Reperfusion Injury: A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(24):235-242.
卢志刚,杨昌明,孔祥辉等.醒脑开窍中药治疗脑缺血再灌注损伤作用机制的研究进展[J].中国实验方剂学杂志,2021,27(24):235-242. DOI: 10.13422/j.cnki.syfjx.20212405.
LU Zhi-gang,YANG Chang-ming,KONG Xiang-hui,et al.Mechanism of Chinese Medicine in Xingnao and Kaiqiao Against Cerebral Ischemia/Reperfusion Injury: A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(24):235-242. DOI: 10.13422/j.cnki.syfjx.20212405.
脑缺血再灌注损伤(CIRI)是缺血性卒中(IS)的共同特征和主要病理生理机制,是脑组织在缺血缺氧的基础上恢复血液后,脑组织结构和功能损伤反而加重,甚至发生不可逆损伤的现象,严重影响患者生存质量,甚至危及生命。因此,寻找脑CIRI的确切机制和有效的治疗靶点及药物是目前迫切需要解决的问题。醒脑开窍中药在治疗CIRI方面应用广泛,成为IS的经典疗法。近年来学者运用现代科学方法对醒脑开窍中药的作用机制及治疗靶点进行了广泛深入的研究,发现活醒脑开窍中药可干预IS发生后的一系列变化过程,取得显著疗效。文章总结近醒脑开窍中药治疗CIRI的作用及其机制,包括抑制炎症反应和氧化应激、减轻脑水肿和兴奋性氨基酸毒性、减少细胞凋亡、促进血管新生及神经血管重塑及改善血脑屏障损伤等几个方面,以期为明确醒脑开窍中药抗CIRI作用机制及重要靶点提供参考,为醒脑开窍中药脑保护的深入研究和应用提供思路。
Cerebral ischemia/reperfusion injury (CIRI) is a common feature and the main pathophysiological mechanism of ischemic stroke(IS), which is caused by a blood reperfusion injury in ischemic brain tissues. It can aggravate brain tissue injury and cause irreversible brain damage, seriously affecting the quality of life or even the life of patients. Hence, we must find out the exact mechanism as well as the effective therapeutic drugs and targets for CIRI. The Chinese medicine effective in Xingnao (restoring consciousness) and Kaiqiao (opening orifices) has been widely used in the treatment of CIRI and serves as a classic therapy for IS. In recent years, scholars have conducted extensive and in-depth studies on the mechanism and therapeutic targets of Chinese medicine in Xingnao and Kaiqiao. They found that those drugs could interfere with a series of changes after IS and achieve the remarkable curative effect. This study summarized the effect and mechanism of Chinese medicine in Xingnao and Kaiqiao in the treatment of CIRI, including reducing the inflammatory response and oxidative stress, alleviating brain edema and the toxicity of excitatory amino acids, reducing cell apoptosis, promoting angiogenesis and neurovascular remodeling, and improving blood-brain barrier injury. It is expected to provide references to clarify the mechanism and important targets of those drugs in resisting CIRI and ideas for the in-depth investigation and application of brain protection of Chinese medicine in Xingnao and Kaiqiao.
醒脑开窍中药脑缺血再灌注损伤神经保护作用机制
Chinese medicine in Xingnao and Kaiqiaocerebral ischemia/reperfusion injury(CIRI)neuroprotective effectmechanism of action
BENJAMIN E J,VIRANI S S,CALLAWAY C W,et al.Heart disease and stroke statistics-2018 update: a report from the american heart association[J].Circulation,2018,137:e67-e492.
DIRNAGI U,SIMON R P,HALLENBECK J M.Ischemic tolerance and endogenous neuroprotection[J].Trends Neurosci,2003,26(5):248-254.
CAMPBELL B C,MITCHELL P J,KLEINIG T J,et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection[J].N Engl J Med,2015,372(11):1009-1018.
NOGUEIRA R G,JADHAV A P,HAUSSEN D C, et al.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct[J].N Engl J Med,2018,378(1):11-21.
RIBO M,MOLINA C A,C0BO E,et al.Association between time to reperfusion and outcome is primarily driven by the time from imaging to reperfusion[J].Stroke,2016,47(4):999-1004.
ELTZSCHIG H K,ECKLE T.Ischemia and reperfusion--from mechanism to translation[J].Nat Med,2011,17(11):1391-1401.
ZHU L,HE D,HAN L,et al.Stroke research in China over the past decade: analysis of NSFC funding transl[J].Transl Stroke Res,2015,6(4):253-256.
杨小钰,黄海红,谌泽芳,等.张伟.脑缺血再灌注后炎症反应研究进展及中西医结合防治思路[J].中国现代医药杂志,2019,21(12):95-99.
田超,袁梦晨,王晓峰,等.醒脑开窍药治疗中风病实验研究进展[J].中西医结合心脑血管病杂志[J].2018,16(15):2158-2161.
CHEN C Y,LI T T,ZHAO Y C,et al.Platelet glycoprotein receptor Ib blockade ameliorates experimental cerebral ischemia-reperfusion injury by strengthening the blood-brain barrier function and anti-thrombo-inflammatory property[J].Brain Behav Immun,2018,69:255-263.
王振凤,田克姚,刘南海.醒脑静注射液对MCAO大鼠神经功能、神经细胞炎症及氧化应激损伤的影响[J].中国现代医生,2020,58(36):36-39.
李震,陈磊,肖明,等.醒脑静注射液在急性脑出血治疗中的临床疗效和安全性[J].世界中医药,2019,14(3):661-665.
李敏,武璞,吕腾,等.醒脑静提取物对脑缺血再灌注炎性损伤5-LOX-CysLTs-CysLT通路的影响[J].中药药理与临床,2015,31(6):131-134.
廖卫宁,杨丽,张合,等.基于TLR4/NF-κB信号通路探讨醒脑静改善反复缺血-再灌注脑损伤小鼠学习记忆能力的作用研究[J].中国医学创新,2019,16(21):30-34.
武璞.醒脑静抗大鼠脑缺血再灌注炎性损伤机制的研究[D].咸阳:陕西中医药大学,2015.
李春雷,黄川锋,张峰.醒脑静注射液联合醒脑窍法对脑缺血再灌注大鼠血清及脑组织炎症因子水平的影响[J].中国临床药理学杂志,2016,32(20):1873-1877.
ZHANG Y M,QU X Y,TAO L N,etal.XingNaoJing injection ameliorates cerebral ischaemia/reperfusion injury via SIRT1-mediated inflammatory response inhibition[J].Pharm Bio,2020,58(1):16-24.
颜俊文,陈澜,王艳英,等.安宫牛黄丸对大鼠脑缺血再灌注损伤和脑外伤的保护作用[J].遵义医学院学报,2017,40(3):249-253.
刘宗涛,沙地克·沙吾提,李继彬,等.安宫牛黄丸对实验性大鼠脑缺血的保护作用[J].中西医结合心脑血管病杂志,2011,9(6):710-712.
李继中,江艳,曾艳,等.安宫牛黄丸对大鼠急性脑缺血再灌注MMP9、AQP4表达的影响[J].遵义医学院学报,2019,42(4):412-415.
刘磊,卫昊,徐立.不同剂量麝香、冰片对大鼠脑IR模型神经功能缺损评分、脑COX-2和5-LOX活性及海马CysLT2表达的影响[J].临床和实验医学杂志,2018,17(12):1241-1244.
邵新然,蔡克瑞,贾茹,等.冰片对脑缺血再灌注损伤模型大鼠炎症反应和血脑屏障通透性的影响[J].中国临床药理学杂志,2018,34(13):1558-1560.
LIU R,ZHANG L,LAN X,et al.Protection by borneol on cortical neurons against oxygen-glucose deprivation/reperfusion: involvement of anti-oxidation and anti-inflammation through nuclear transcription factor κappaB signaling pathway[J].Neuroscience,2011,176:408-419.
文静,王建,陈念,等.苏合香对永久性大脑中动脉栓塞大鼠模型的脑保护及其机制研究[J].时珍国医国药,2017,28(10):2305-2308.
赵培,岳少乾,马妍.苏合香对脑微血管内皮细胞氧糖剥夺/复氧损伤的影响[J].中国临床药理学杂志,2016,32(9):847-849.
ZHANG M,MA Y,CHAI L J,et al.Storax protected oxygen-glucose deprivation/reoxygenation induced primary astrocyte injury by inhibiting NF-κB activation in vitro[J].Front Pharmacol,2019,9:1527.
倪彩霞,曾南,汤奇,等.芳香开窍药对脑缺血再灌注损伤大鼠的保护作用及其机制初探[J].中药药理与临床,2010,26(5):64-66.
倪彩霞,曾南,苟玲,等.芳香开窍药对脑缺血再灌注损伤大鼠保护作用机制的研究[J].中药药理与临床,2011,27(5):65-68.
KASSNER A,MERALI Z.Assessment of blood-brain barrier disruption in stroke[J].Stroke,2015 ,46(11):3310-3315.
张红波,代建峰,张宾辉.醒脑静注射液对脑缺血再灌注氧化损伤的实验研究[J].浙江中医药大学学报,2006,(3):233-234,237.
王万铁,陈寿权,王卫,等.醒脑静注射液对实验性脑缺血及再灌注损伤中氧自由基水平的影响[J].中医药学刊,2004,22(3):434-435.
黄丽,朱彩霞,张芹欣,等.四种开窍药对急性不完全性脑缺血再灌注损伤模型大鼠的脑保护作用[J].中国比较医学杂志,2018,28(8):77-82.
倪彩霞,曾南,汤奇,等,芳香开窍药对脑缺血再灌注损伤大鼠的保护作用及其机制初探[J].中药药理与临床,2010,26(5):64-66.
董世芬,楼黎明,等.安宫牛黄丸(含天然麝香或人工麝香)对实验性脑缺血的保护作用[J].世界科学技术—中医药现代化,2013,15(1):85-90.
陈雨,林高城,白亮.苏合香挥发油对脑缺血再灌注诱导神经细胞损伤的影响[J].中成药,2020,42(12):3298-3302.
黄菊阳,王昭昕,王少侠,等.醒脑静注射液活性成分对氧糖剥夺/复氧损伤的PC12细胞的保护作用研究[J].中国临床药理学杂志,2020,36(10):1337-1340.
张颖,蒋玉凤,刘智勤,等.丹酚酸B对小鼠脑缺血不同时间脑能量代谢及脑水肿的作用[J].药学学报,2007,42(12):1250-1253.
SHU Q,FAN H,LI S,et al.Protective effects of Progranulin against focal cerebral ischemia-reperfusion injury in rats by suppressing endoplasmic reticulum stress and NF-κB activation in reactive astrocytes[J].J Cell Biochem,2018,119(8):6584-6597.
ZHANG Y M,QU X Y,ZHAI J H.Xingnaojing injection protects against cerebral ischemia reperfusion injury via PI3K/Akt-mediated eNOS phosphorylation[J].Evid Based Complement Alternat Med,2018,doi: 10.1155/2018/2361046http://dx.doi.org/10.1155/2018/2361046.
沈婷,袁婕,常莎,等.醒脑静联合缺血预适应对脑缺血再灌注损伤大鼠细胞凋亡的影响[J].湖南师范大学学报:医学版,2020,17(5):30-33.
吴丽君.醒脑静注射液保护脑缺血急性期半暗带损伤的实验研究[D].北京:北京中医药大学,2017.
王国骅,向军,兰瑞,等.安宫牛黄丸对急性缺血大鼠神经元凋亡及其磷酸化Akt表达的影响[J].中成药,2012,34(10):1866-1869.
方永奇,李翎,邹衍衍,等.石菖蒲对缺血-再灌注脑损伤大鼠脑电图和脑水肿的影响[J].中国中医急症,2003,12(1):55-56,6.
夏鑫华,刘亚敏,赵光峰,等.麝香配伍冰片对局灶性脑缺血再灌注大鼠神经元突触超微结构的影响[J].江西中医学院学报,2008,20(1):56-58.
方永奇,匡忠生,谢宇辉,等.石菖蒲对缺血再灌注脑损伤大鼠神经细胞凋亡的影响[J].现代中西医结合杂志,2002,11(17):1647-1649.
杨迪,王桂敏,翟宏颖.菟丝子黄酮对脑缺血再灌注损伤模型大鼠脑组织中炎症反应的影响[J].中国药房,2013,24(11):979-982.
钟志越,李炳,刘明,等.醒脑静注射液对全脑缺血再灌注大鼠血脑屏障ZO-1表达的影响[J].中国病理生理杂志,2015,31(7):1320-1323.
XIAO Y Q,ZHANG Y M,TAO L N,et al.XingNaoJing injections protect against cerebral ischemia/reperfusion injury and alleviate blood-brain barrier disruption in rats,through an underlying mechanism of NLRP3 inflammasomes suppression[J].Chin J Nat Med,2019,17(7):498-505.
曲晓宇,张月明,张四喜,等.醒脑静注射液保护大鼠脑缺血-再灌注损伤及血脑屏障的作用研究[J].中药材,2018,41(9):2196-2200.
倪彩霞,曾南,汤奇,等.芳香开窍药对脑缺血再灌注损伤小鼠血脑屏障通透性的影响[J].时珍国医国药,2011,22(11):2639-2640.
倪彩霞,曾南,许福会,等.芳香开窍药对脑缺血再灌注损伤大鼠血脑屏障影响的实验研究[J].中国中药杂志,2011,36(18):2562-2566.
赵光峰,刘亚敏,黄宏敏,等.芳香开窍法对大鼠脑缺血再灌注后血脑屏障超微结构损伤及AQP-4表达的影响[J].海南医学,2013,24(14):2029-2031.
刘亚敏,赵光峰,夏鑫华,等.麝香配伍冰片对缺血再灌注损伤后血脑屏障的影响[J].北京中医药,2009,28(6):459-462.
徐秋英,刘亚敏,沈强,等.人工麝香对大鼠局灶性脑缺血再灌注后大脑MMP-9 mRNA及其蛋白表达的影响[J].热带医学杂志,2011,11(8):875-878,997.
李东娜,马静,李莉莉,等.苏合香对脑缺血再灌注损伤大鼠的脑保护及血脑屏障开放作用研究[J].药物评价研究,2020,43(10):1977-1982.
肖一鑫,章纪叶,刘佳奕,等.石菖蒲煎剂对不同时长急性脑缺血再灌注大鼠BBB保护效应的研究[J].成都中医药大学学报,2016,39(2):32-35.
ZHAO G C,YUAN Y L,CHAI F R,et al.Effect of Melilotus officinalis extract on the apoptosis of brain tissues by altering cerebral thrombosis and inflammatory mediators in acute cerebral ischemia[J].Biomed Pharmacother,2017,89:1346-1352.
CHENG C Y,HO T Y,HSIANG C Y,et al.Angelica sinensis exerts angiogenic and anti-apoptotic effects against cerebral ischemia-reperfusion injury by activating p38MAPK/HIF-1αα/VEGF-A signaling in rats[J].Am J Chin Med,2017,45(8):1683-1708.
刘颂华,胡结明,方锦霞,等.醒脑静注射液对缺氧缺血性脑损伤大鼠S100B蛋白及低氧诱导因子-1α和血管内皮生长因子表达的影响[J].中华实用诊断与治疗杂志,2015,29(12):1176-1178.
文静,王建,陈念.安息香对永久性大脑中动脉栓塞大鼠模型的保护作用及其机制研究[J].中国药理学通报,2016,32(12):1683-1687.
周敏,范祥,朱金墙,等.苏合香早期干预促进大鼠脑缺血后长期神经功能修复[J].天津中医药,2017,34(9):621-625.
RAMANATHAN M,BABU C S,JUSTIN A,et al.Elucidation of neuroprotective role of endogenous GABA and energy metabolites in middle cerebal artery occluded model in rats[J].Indian J Exp Biol,2012,50(6):391-397.
肖玉强,张良玉,唐海涛,等.冰片促进砷剂透过血脑屏障实验研究中华神经外科疾病研究杂志,2007,6(3):244-246.
朱坤杰,孙建宁,马长华,等.安宫牛黄丸及重金属组分对内毒素脑损伤大鼠大脑皮层单胺类递质的影响[J].中国中药杂志,2007,32(10):949-953.
牟菲,蔺瑞,张海悦,等.基于代谢组学方法研究中药苏合香对冠心病心血瘀阻证大鼠的干预作用[J].中国新药杂志,2019,28(5):620-627.
李欢,夏鑫华,刘梅,等.麝香配伍冰片干预局灶性脑缺血-再灌注损伤的代谢组学研究[J].中药材.2012,35(8):1274-1279.
张卫同,柴栋,徐珊,等.石菖蒲对脑缺血大鼠纹状体氨基酸类神经递质含量变化的影响[J].中国应用生理学杂志.2014,30(4):352-356.
YU L,WANG N,ZHANG Y,et al.Neuroprotective effect of muscone on glutamate- induced apoptosis in PC12 cells via antioxidant and Ca2+ antagonism[J].Neurochem Int,2014,70:10-21.
肖珍科,黎贤泰,王保,等.麝香酮处理后CIRI模型大鼠海马组织中S100β、NF-κB表达变化研究[J].陕西中医.2019,40(10):1327-1329.
0
Views
15
下载量
4
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution